InsiderClue
Insiders · Profile

KIM PETER S

Director at Entrada Therapeutics · Exe V-P & Pres, MRL at Merck. Filing since 5 Nov 2012. CIK 0001181180

TRDA Entrada Therapeutics, Inc. Director · 11 trades MRK Merck & Co. Exe V-P & Pres, MRL · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
14 May 2024
Director
Bought
25,000
$364.67K
37.1%
TRDA Entrada Therapeutics, Inc.
9 May 2024
Director
Bought
2,200
$31.34K
3.4%
TRDA Entrada Therapeutics, Inc.
8 May 2024
Director
Bought
2,276
$31.96K
3.6%
TRDA Entrada Therapeutics, Inc.
8 Apr 2024
Director
Bought
2,600
$35.29K
4.3%
TRDA Entrada Therapeutics, Inc.
28 Mar 2024
Director
Bought
1,512
$20.79K
2.6%
TRDA Entrada Therapeutics, Inc.
26 Mar 2024
Director
Bought
2,750
$37.51K
4.9%
TRDA Entrada Therapeutics, Inc.
25 Mar 2024
Director
Bought
3,180
$42.47K
6.0%
TRDA Entrada Therapeutics, Inc.
22 Mar 2024
Director
Bought
3,118
$42.90K
6.3%
TRDA Entrada Therapeutics, Inc.
21 Mar 2024
Director
Bought
704
$9.32K
1.4%
TRDA Entrada Therapeutics, Inc.
20 Mar 2024
Director
Bought
1,128
$14.28K
2.4%
TRDA Entrada Therapeutics, Inc.
19 Mar 2024
Director
Bought
900
$11.40K
1.9%
MRK Merck & Co.
5 Nov 2012
Exe V-P & Pres, MRL
Sold, plan not stated
420,000
$19.11M
71.1%
12 decisions on file.